News|Articles|February 12, 2026
FDA Action Update, January 2026: Approvals, Acceptance, and Clearance
Author(s)Isabella Ciccone, MPH
Fact checked by: Kelly King
Catch up on any of the neurology headlines you may have missed in January 2026, compiled into 1 place by the NeurologyLive® team.
Advertisement
Advertisement
The FDA was busy in January 2026, making a number of decisions on potential new therapeutic agents, including granting approvals, a designation, an acceptance, a clearance, and a priority review, as well as requesting a clinical study report.
Advertisement
Advertisement